Related content

CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin

By Elens Laure   Nieuweboer Annemieke   Clarke Stephen J   Charles Kellie A   de Graan Anne-Joy   Haufroid Vincent   Mathijssen Ron HJ   van Schaik Ron HN  

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 137-149

Future Medicine

Access to resources Recommend Favorite

CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients

By Gijsen Violette MGJ   van Schaik Ron HN   Elens Laure   Soldin Offie P   Soldin Steven J   Koren Gideon   de Wildt Saskia N  

Pharmacogenomics, Vol. 14, Iss. 9, 2013-07 ,pp. : 1027-1036

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects

By Eap Chin   Buclin Thierry   Hustert Elisabeth   Bleiber Gabriela   Golay Kerry   Aubert Anne-Catherine   Baumann Pierre   Telenti Amalio   Kerb Reinhold  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 4, 2004-06 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite

Statin regulation of CYP3A4 and CYP3A5 expression

By Willrich Maria Alice Vieira   Hirata Mario Hiroyuki   Hirata Rosario Dominguez Crespo  

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 1017-1024

Future Medicine

Access to resources Recommend Favorite

Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43

By Krusekopf S.   Roots I.   Kleeberg U.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 7-12

Elsevier

Access to resources Recommend Favorite